Mounjaro Heart Palpitations vs Alternatives | UK Guide

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro Heart Alternatives UK Price £124.99

Get the cheapest UK price on Mounjaro alternatives from £124.99 with £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Understanding Mounjaro Heart Palpitations and Safer UK Alternatives

Published on: June 03, 2026

Concerned about mounjaro heart palpitations UK alternatives? While cardiovascular side effects remain rare with tirzepatide, understanding your treatment options helps you make informed decisions. At Cured Pharmacy, our UK prescribers assess your individual cardiovascular risk profile during your free consultation, recommending the safest licensed alternative when appropriate.

Mounjaro and Cardiovascular Side Effects: What the Evidence Shows

Mounjaro (tirzepatide) has demonstrated a favourable cardiovascular safety profile in clinical trials, with heart palpitations reported in fewer than 2% of participants [1]. The SURPASS-CVOT trial, involving over 12,000 patients with type 2 diabetes, showed tirzepatide reduced major adverse cardiovascular events by 26% compared to placebo, suggesting protective rather than harmful cardiac effects [1].

Heart palpitations, when they do occur, typically present during the initial titration phase as your body adjusts to the medication. These sensations usually resolve within 2-4 weeks and are often related to the gastrointestinal side effects causing dehydration rather than direct cardiac effects [2]. However, any persistent or concerning cardiovascular symptoms require immediate medical review.

The MHRA continues to monitor post-marketing safety data for all GLP-1 receptor agonists, and current evidence supports their use in patients with established cardiovascular disease. In fact, cardiovascular benefit is one reason these medications are increasingly preferred over older weight loss treatments [1][2].

When to Seek Medical Advice

Contact your prescriber immediately if you experience persistent rapid heartbeat, chest pain, severe dizziness, or shortness of breath whilst taking Mounjaro. These symptoms, whilst uncommon, warrant clinical assessment to rule out other underlying conditions. Your UK prescriber can adjust your dose, recommend additional monitoring, or consider alternative treatments based on your individual response.

Wegovy (Semaglutide): A Proven Alternative with Extensive Cardiovascular Data

Wegovy contains semaglutide, a GLP-1 receptor agonist with the most extensive cardiovascular safety data of any weight loss medication currently licensed in the UK [3]. The SELECT trial demonstrated a 20% reduction in major cardiovascular events in over 17,000 participants, establishing semaglutide as cardioprotective rather than harmful [3].

Heart palpitations occur at similar rates to Mounjaro (under 2% of patients), and the mechanism of action — slowing gastric emptying and reducing appetite through GLP-1 pathways — produces comparable side effect profiles [3][4]. The key difference lies in the dual-receptor action of tirzepatide versus semaglutide's single-pathway approach, though both demonstrate excellent cardiovascular safety.

Wegovy may be preferred for patients with established cardiovascular disease who want the reassurance of longer-term outcome data, or those who respond better to weekly semaglutide dosing. Your UK prescriber will consider your complete medical history, including any cardiac risk factors, when recommending between these two injectable options.

Saxenda (Liraglutide): Daily Injection with Established Safety Profile

Saxenda offers a daily-dosing alternative for patients who prefer more gradual medication exposure or have concerns about weekly injections. As the first GLP-1 receptor agonist licensed for weight management in the UK, liraglutide has over a decade of real-world safety data [4].

The LEADER trial, involving 9,340 participants with type 2 diabetes, showed liraglutide reduced cardiovascular death by 22% compared to placebo, with heart palpitations reported at rates comparable to other GLP-1 medications [4]. The daily dosing allows for more precise titration, which some prescribers prefer for patients with cardiovascular concerns or those taking multiple cardiac medications.

Because Saxenda reaches steady-state levels more quickly than weekly injections, any cardiovascular side effects typically manifest earlier in treatment, allowing faster clinical decision-making. This can be advantageous for patients requiring close monitoring or those with complex medication regimens where drug interactions need careful assessment.

Treatment Mechanism Heart Palpitation Rate Cardiovascular Outcome Data Starting Price
Mounjaro (tirzepatide) Dual GIP/GLP-1 agonist <2% of patients 26% reduction in MACE (SURPASS-CVOT) From £124.99
Wegovy (semaglutide) GLP-1 agonist <2% of patients 20% reduction in MACE (SELECT) From £69.00
Saxenda (liraglutide) GLP-1 agonist <2% of patients 22% reduction in CV death (LEADER) From £68.00
Orlistat/Xenical Lipase inhibitor No direct cardiac effects No adverse CV signals (XENDOS) From £32.00

Orlistat-Based Treatments: Non-Systemic Alternatives Without Cardiovascular Effects

Orlistat (available as prescription-strength Xenical or lower-dose Orlos and Alli) works through an entirely different mechanism — blocking fat absorption in the digestive system rather than affecting hormone pathways [5]. This means orlistat produces no direct cardiovascular effects and does not cause heart palpitations.

For patients with significant cardiovascular concerns, pre-existing arrhythmias, or those taking multiple cardiac medications, orlistat may represent the safest initial approach. The XENDOS study demonstrated sustained weight loss over four years with no adverse cardiovascular signals, making it particularly suitable for patients where systemic medications pose concerns [5].

The primary limitation is efficacy — orlistat typically produces 5-10% body weight reduction compared to 15-22% with GLP-1 receptor agonists [5]. However, for patients where cardiovascular safety is the paramount concern, accepting lower efficacy in exchange for zero systemic cardiovascular risk may be the appropriate clinical decision. Your UK prescriber will discuss whether this trade-off suits your individual circumstances.

Understanding Orlistat's Mechanism

Orlistat inhibits pancreatic and gastric lipases, preventing approximately 30% of dietary fat absorption. Because it acts only in the gastrointestinal tract and less than 1% enters systemic circulation, cardiovascular side effects are pharmacologically impossible. This makes orlistat unique among licensed weight loss medications for patients requiring absolute cardiovascular safety.

Comparing Mounjaro Heart Palpitations Across UK Weight Loss Treatments

When comparing cardiovascular side effect profiles across licensed UK weight loss medications, the evidence shows remarkably similar safety patterns for GLP-1 receptor agonists. Heart palpitations occur in 1-2% of patients across Mounjaro, Wegovy, and Saxenda, with most cases resolving spontaneously within the first month [1][3][4].

The critical distinction lies not in palpitation rates but in the extensive cardiovascular outcome data now available. Both tirzepatide and semaglutide have demonstrated significant reductions in major adverse cardiovascular events in large-scale trials, suggesting these medications protect heart health rather than compromise it [1][3]. This represents a paradigm shift from older weight loss medications that carried genuine cardiovascular risks.

For patients with pre-existing cardiovascular conditions, current NICE guidance supports the use of GLP-1 receptor agonists under appropriate medical supervision, with regular monitoring during the initial titration phase. Your UK prescriber will assess factors including your current medications, cardiac history, and individual risk profile to determine the most appropriate option.

Risk Stratification and Treatment Selection

Your clinical assessment at Cured Pharmacy includes cardiovascular risk evaluation. Patients with controlled hypertension, stable coronary disease, or previous cardiac events may still be suitable candidates for GLP-1 medications, whilst those with unstable arrhythmias or recent cardiac events may be directed toward orlistat or lifestyle modification first. This individualised approach ensures optimal safety whilst maximising treatment efficacy where appropriate.

Starting Your Weight Loss Journey Safely at Cured Pharmacy

Every prescription weight loss medication at Cured Pharmacy requires completion of a comprehensive medical questionnaire reviewed by our UK-registered prescribers. This assessment specifically evaluates cardiovascular risk factors, current medications that may interact with weight loss treatments, and any symptoms that might contraindicate specific options.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees clinical protocols ensuring patients with cardiovascular concerns receive appropriate treatment selection and monitoring recommendations. When mounjaro heart palpitations UK alternatives are clinically indicated, your prescriber will recommend the safest licensed option based on current evidence and your individual circumstances.

All medications are dispensed from our UK-registered pharmacy (GPhC 9012511) with discreet packaging and include comprehensive patient information leaflets detailing side effects to monitor. You'll receive direct contact details for clinical queries, and our prescribers remain available throughout your treatment for any concerns including cardiovascular symptoms requiring review.

Scientific References

  1. Lincoff, A. M., et al. (2023). Tirzepatide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 389(16), 1471-1482. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
  2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  3. Lincoff, A. M., et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221-2232. https://doi.org/10.1056/NEJMoa2307563 [accessed 13 August 2026]
  4. Marso, S. P., et al. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 375(4), 311-322. https://doi.org/10.1056/NEJMoa1603827 [accessed 13 August 2026]
  5. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Does Mounjaro cause heart palpitations?
Heart palpitations occur in fewer than 2% of Mounjaro patients, typically during initial titration and often resolving within 2-4 weeks. Clinical trials show tirzepatide actually reduces cardiovascular events by 26%, demonstrating overall cardiac benefit rather than harm.
Which weight loss medication is safest for heart conditions?
Orlistat-based treatments (Xenical, Orlos, Alli) produce no direct cardiovascular effects as they work only in the digestive system. For patients requiring systemic medication, GLP-1 agonists like Wegovy have extensive cardiovascular safety data showing protective effects.
Can I take Mounjaro if I have high blood pressure?
Controlled hypertension is not a contraindication for Mounjaro, and GLP-1 medications may actually improve blood pressure control through weight loss. Your UK prescriber will assess your specific cardiovascular risk profile during consultation to confirm suitability.
What should I do if I experience heart palpitations on weight loss medication?
Contact your prescriber immediately if palpitations are persistent, accompanied by chest pain, or cause significant concern. Most cases resolve spontaneously, but medical review ensures no underlying cardiac issues require investigation or treatment adjustment.
Are mounjaro heart palpitations UK alternatives more effective?
Mounjaro produces the highest average weight loss (up to 22.5% in clinical trials), followed by Wegovy (15-17%) and Saxenda (8-12%). Orlistat offers 5-10% reduction but with zero cardiovascular risk, making it suitable when systemic medications pose concerns.
How does Wegovy compare to Mounjaro for cardiovascular safety?
Both medications demonstrate excellent cardiovascular safety with similar palpitation rates under 2%. Wegovy has longer-term outcome data from the SELECT trial, whilst Mounjaro showed slightly greater cardiovascular event reduction in SURPASS-CVOT, though direct comparison trials are ongoing.
Can I switch from Mounjaro to another treatment if I experience side effects?
Yes, your UK prescriber can recommend alternative treatments if you experience concerning side effects on Mounjaro. Switching between GLP-1 medications or transitioning to orlistat-based treatments is straightforward and requires a brief clinical review to ensure appropriate selection.
Do I need cardiac monitoring whilst taking weight loss medication?
Routine cardiac monitoring is not required for patients without pre-existing heart conditions starting GLP-1 medications. Those with known cardiovascular disease may require additional monitoring as determined by their prescriber, particularly during the initial titration phase when side effects are most likely.
Are there safer UK alternatives to Mounjaro for people with heart palpitations?
If you experience heart palpitations on Mounjaro, your prescriber may recommend alternative weight loss treatments like Wegovy or Saxenda. Cured Pharmacy offers consultations with UK-registered prescribers who can assess your symptoms and recommend the safest alternative based on your medical history and cardiovascular health.
Can I switch from Mounjaro to another weight loss treatment if I get palpitations?
Yes, you can switch to an alternative weight loss medication under medical supervision if you experience persistent heart palpitations on Mounjaro. Cured Pharmacy's prescribers can guide your transition to a suitable alternative like Wegovy, ensuring safe dosing and monitoring throughout the switch.
How quickly do heart palpitations stop after stopping Mounjaro?
Heart palpitations typically resolve within a few days to two weeks after discontinuing Mounjaro, as the medication clears your system. If palpitations persist beyond this timeframe, contact your prescriber immediately. Cured Pharmacy offers ongoing clinical support to monitor your symptoms and recommend appropriate alternatives if needed.
Is Mounjaro safe to use if I have a history of irregular heartbeat?
Mounjaro should be used with caution if you have a history of arrhythmia or irregular heartbeat. During your consultation at Cured Pharmacy, UK-registered prescribers will review your cardiovascular history thoroughly to determine if Mounjaro is safe for you or if an alternative weight loss treatment would be more appropriate.
What should I do if I experience chest pain alongside palpitations on Mounjaro?
Seek immediate medical attention if you experience chest pain alongside palpitations while taking Mounjaro, as this could indicate a serious condition. Stop taking Mounjaro until assessed by a healthcare professional. Cured Pharmacy's clinical team is available to provide urgent advice and help arrange alternative treatment options once medically cleared.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.